Patent · US Active

Validation of continuous viral clearance

US10894991B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Benjamin MAISER · Leverkusen, DE
Peter SCHWAN · Leverkusen, DE
Laura DAVID · Quezon, PH
Martin LOBEDANN · Cologne, DE

Key dates

Filing date	Oct 20, 2017
Grant date	Jan 19, 2021
Priority date	—
Expiry date	Oct 20, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/005
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein is a method for validation of continuous viral clearance comprising the steps of providing a probe to be validated, spiking the probe in a valid manner, performing viral clearance, sampling the spiked probe and analyzing the sample of the spiked probe of step d).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.